fda ruling on semaglutide FDA's Removal of and the Evolving Tirzepatide Decisions: What Compounders Need to Know FDA free to pursue semaglutide
Description
Future research should continue to explore its therapeutic potential in under-studied populations, including individuals with non-diabetic cardiovascular disease and hepatic fibrosis.
Find out if you're a good candidate for GLP-1s
Rosenthal SB
Switching from Ozempic to Mounjaro (or back)
In an attempt to compensate for the loss, other pathways are upregulated, e.g., the increased use of ketones produced from fatty acids by astrocytes that are shuttled to neurons
